cells
virus
infection
viral
cell
protein
study
data
al
figure
viruses
patients
fig
human
infected
rna
expression
disease
proteins
results
analysis
influenza
time
studies
mice
specific
based
control
samples
health
high
number
gene
shown
table
found
group
observed
respiratory
host
response
activity
model
cases
pcr
reported
compared
levels
anti
ml
type
positive
binding
including
immune
cov
genes
performed
showed
clinical
dna
replication
treatment
ifn
sequence
infections
significant
sequences
identified
system
detected
similar
il
increased
higher
species
induced
antibody
days
important
genome
role
level
due
effect
addition
significantly
assay
total
strains
potential
previously
sars
risk
antibodies
vaccine
low
detection
population
groups
infectious
hiv
transmission
min
diseases
case
responses
acid
present
test
related
day
production
single
mers
obtained
strain
rate
animals
effects
factors
information
presence
age
mm
sample
region
years
research
development
treated
negative
membrane
severe
activation
serum
increase
method
blood
antiviral
target
collected
mouse
animal
lower
methods
cellular
function
values
children
pathogens
large
structure
models
site
demonstrated
lung
post
usa
previous
determined
receptor
expressed
early
public
amino
multiple
tested
small
additional
differences
highly
acute
culture
domain
complex
included
outbreak
ii
reduced
mediated
incubated
considered
analyzed
process
care
result
s1
molecular
patient
dependent
surface
common
involved
major
signaling
inflammatory
primary
antigen
developed
interaction
confirmed
bacterial
size
pbs
range
china
conditions
effective
required
tissue
factor
sites
regions
recent
concentration
period
rsv
experiments
individuals
countries
set
vitro
derived
epidemic
evidence
humans
peptide
pedv
order
entry
mrna
pathway
approach
pathogen
length
vaccines
surveillance
provide
individual
isolated
determine
laboratory
recombinant
symptoms
mg
medium
family
distribution
inhibition
fusion
findings
genetic
transcription
mortality
hospital
fold
sequencing
assays
vector
revealed
temperature
vaccination
standard
end
growth
buffer
analyses
generated
selected
contrast
coronavirus
long
residues
interactions
reaction
usepackage
times
added
recently
show
hcv
systems
form
particles
suggest
identify
measured
ha
wild
vivo
mechanism
types
contact
spread
limited
ph
pandemic
μl
provided
ability
mechanisms
relative
rates
work
conducted
wt
free
year
suggesting
kit
life
average
drug
prior
secondary
real
network
medical
difference
zikv
structural
nm
impact
calculated
dose
current
bat
applied
°c
caused
h1n1
formation
include
consistent
cancer
concentrations
immunity
phase
global
igg
active
full
decreased
primers
reference
pneumonia
outbreaks
resulting
defined
purified
peptides
software
change
independent
protection
cd4
bacteria
exposure
line
support
bats
expressing
cross
step
terminal
structures
macrophages
pigs
selection
sensitivity
general
point
initial
functional
association
mutations
controls
produced
pathways
induce
populations
reduction
direct
tissues
molecules
pre
critical
induction
suggested
challenge
functions
national
conserved
complete
synthesis
absence
local
nucleotide
directly
experimental
evaluated
ca
cd8
presented
genomes
death
comparison
key
reverse
signal
transfected
final
cycle
part
products
washed
essential
hours
cytokines
estimated
acids
ratio
syndrome
prevalence
approximately
testing
numbers
expected
fever
areas
supplementary
biological
knowledge
plasma
weeks
receptors
diagnosis
made
parameters
state
lines
quality
future
innate
mutant
plasmid
people
detect
inflammation
μg
ibv
greater
epithelial
activities
events
specificity
genomic
indicating
incidence
identification
statistical
shows
liver
natural
inhibitor
incubation
review
elisa
resistance
increasing
titers
primer
lack
report
resulted
interestingly
rapid
water
examined
participants
np
chronic
loss
western
normal
reads
compounds
apoptosis
score
plates
ms
highest
predicted
understanding
cytokine
weight
neutralizing
linked
isolates
measures
main
regulation
world
months
affected
gfp
suggests
investigated
targeting
amplification
strategies
solution
polymerase
therapy
tumor
area
tract
combination
field
brain
community
mutation
survival
play
leading
strong
lead
release
established
stress
correlation
reduce
finally
therapeutic
efficacy
class
activated
database
phylogenetic
diagnostic
characterized
assessed
severity
s2
enhanced
inhibit
agents
inhibitors
tests
flow
protective
patterns
er
illness
reports
strategy
extracted
drugs
carried
domains
decrease
healthy
cats
body
hand
specifically
subsequent
assembly
frequency
generation
manufacturer
needed
enzyme
characteristics
week
cdna
denv
university
volume
fact
remains
chain
scale
iav
targets
protocol
autophagy
points
distinct
scientific
iii
members
translation
responsible
designed
dengue
prrsv
ci
cleavage
media
similarly
pattern
intracellular
proportion
susceptible
subsequently
capacity
staining
short
pro
components
diversity
regulated
design
represent
authors
administration
μm
assess
2a
processes
vero
mass
screening
density
protease
emerging
de
hcov
affect
3a
position
published
nt
sigma
stage
tnf
specimens
room
modified
social
codon
isolation
peak
status
term
pathogenesis
studied
proposed
prevention
approaches
ebola
affinity
relevant
file
occur
antigens
importance
amount
nuclear
fluorescence
vectors
h5n1
efficient
efficiency
prevent
variants
1a
additionally
evaluate
management
variation
fixed
occurred
panel
states
terms
prepared
collection
probability
influence
features
approved
healthcare
located
avian
properties
core
majority
µl
epitope
unique
contribute
improve
encoding
bind
asthma
international
pathogenic
potentially
signs
source
produce
transfection
central
product
performance
evolution
degradation
immunization
1b
gel
inhibited
hepatitis
epitopes
onset
interferon
coding
develop
interest
program
clear
ebov
inoculated
bound
tgev
combined
maximum
phosphorylation
environment
hosts
nf
variables
cultures
investigate
mab
invitrogen
diluted
context
exposed
mixed
stable
unknown
membranes
version
red
live
generate
coli
experiment
sera
received
generally
dpi
37°c
substrate
nasal
na
outcome
subjects
index
quantitative
damage
variable
cluster
wide
cultured
median
sampling
improved
mammalian
close
degree
light
relationship
nucleic
removed
delivery
porcine
increases
bovine
vaccinated
stained
good
2b
led
demonstrate
recombination
icu
inhibitory
resistant
dynamics
epidemiological
environmental
air
sensitive
conjugated
estimates
piglets
criteria
swine
vsv
recognition
genotype
hrv
promoter
date
qpcr
duration
germany
lungs
late
larger
search
cost
gp
supernatant
bp
strand
stability
outcomes
hsv
exhibited
daily
coronaviruses
country
alternative
lipid
manner
double
pulmonary
briefly
contained
commonly
targeted
measure
kg
percentage
agent
rabbit
means
ng
probe
nature
material
history
sirna
glycoprotein
diarrhea
cns
susceptibility
tree
evaluation
developing
hpi
random
mock
kidney
occurs
series
frequently
matrix
training
green
motif
technologies
figures
load
identity
significance
technology
envelope
mhv
genbank
residue
base
luciferase
mutants
dilution
hbv
investigation
proliferation
estimate
finding
amplified
processing
distance
variety
kinase
titer
correlated
difficult
stored
linear
africa
requires
require
forms
molecule
million
infectivity
adults
represents
loop
seasonal
adult
virions
poly
airway
genus
statistically
roles
copies
fraction
mild
tool
side
middle
literature
transport
adenovirus
monoclonal
systemic
noted
dogs
µg
application
strongly
plant
food
oral
instructions
south
mir
accumulation
clusters
injury
longer
moi
extraction
dc
make
transcripts
labeled
focus
trials
access
closely
supplemented
possibility
action
observation
leads
open
regulatory
networks
background
sufficient
pressure
contacts
hospitals
note
minimal
tools
assessment
broad
left
chinese
spike
observations
sections
inoculation
prediction
maintained
similarity
rapidly
mabs
origin
plasmids
complexes
threshold
reporting
µm
intestinal
coverage
minutes
alignment
confirm
stranded
capsid
half
scores
4a
widely
diverse
center
emergency
reactions
stimulation
fragments
workers
recognized
rnas
mixture
compound
poultry
recorded
united
regression
κb
induces
infect
downstream
hypothesis
microscopy
versus
promote
safety
upper
intervention
basic
3b
fluid
fully
tb
failure
supernatants
component
immunized
cat
emergence
mhc
underlying
blot
flu
dcs
event
sds
unit
aa
plaque
signals
content
ace2
dataset
acquired
circulating
basis
showing
stimulated
subjected
rig
units
resources
3d
poor
read
birds
variant
appears
fragment
act
steps
library
harvested
economic
swabs
understand
likelihood
paper
conclusion
interact
constructed
remaining
zoonotic
plate
laboratories
efforts
transfer
optimal
uk
reporter
parameter
plays
profile
stem
evolutionary
virulence
template
murine
medicine
probes
elevated
admission
classified
settings
reducing
existing
burden
chickens
reviewed
intensity
detailed
potent
staff
ct
displayed
stages
particle
extent
lesions
attenuated
neutralization
document
hla
calves
injection
adaptive
earlier
discovery
focused
pneumoniae
secretion
achieved
allowed
enhance
sets
pig
section
subunit
bias
account
hmpv
pairs
internal
pfu
techniques
chikv
candidate
spatial
procedures
curve
remain
progression
policy
young
capable
cohort
called
deaths
synthesized
log
markers
ns1
chicken
compare
aged
rv
worldwide
monitoring
administered
isolate
5a
overnight
deficient
obtain
committee
facilitate
limit
completely
primarily
location
comparable
dmem
clone
survey
organization
2c
ifitm3
sequenced
causing
grown
top
follow
positions
conventional
blue
genotypes
neutrophils
kda
nodes
encoded
phenotype
transferred
commercial
lps
remained
supported
inactivated
elements
localization
interventions
sense
identical
resolution
goat
rnase
cap
rats
crucial
includes
representative
deletion
employed
practice
spleen
cytoplasmic
express
peripheral
guidelines
represented
antibiotics
making
milk
inhibits
procedure
baseline
typically
virion
3c
formed
east
phosphate
condition
lamp
original
4°c
ligand
sources
4b
families
actin
bio
lymphocytes
introduction
introduced
dsrna
algorithm
marker
enzymes
epidemics
equal
problem
blocking
abundance
quantified
fluorescent
ma
block
cycles
differentiation
successfully
antibiotic
initiation
fecal
malaria
place
amounts
page
female
cytoplasm
chemical
controlled
route
pa
composition
env
initially
images
phage
mucosal
iv
thermo
successful
manuscript
importantly
qiagen
restriction
efficiently
differential
shedding
simple
skin
partial
male
nk
energy
ranging
accession
divided
mrnas
past
monocytes
extracellular
clones
h7n9
frame
providing
entire
binds
robust
nucleus
detectable
extract
predict
doses
separate
japan
purchased
blocked
rbd
services
preparation
effectiveness
endogenous
appeared
setting
cough
excluded
profiles
antigenic
rdrp
sodium
morbidity
transcriptional
trial
rabies
challenges
limitations
putative
smaller
find
numerous
moderate
slightly
accuracy
recovery
spectrum
farms
tris
fbs
m2
effectively
explain
infants
fisher
institute
cold
extensive
newly
analysed
processed
alpha
plants
ubiquitin
cloned
interval
west
traditional
ensure
s3
platform
column
government
construct
recruitment
wnv
domestic
reactive
ili
african
travel
display
mitochondrial
purification
inclusion
true
multi
comparing
serial
separated
yield
examine
reagent
soluble
questions
centrifugation
hela
cm
orf
microbial
largely
depending
intensive
agreement
ventilation
forward
minimum
sd
selective
asymptomatic
substantial
terminus
address
asia
a549
confidence
ten
caspase
directed
continuous
season
implementation
notably
st
ad
shared
endothelial
nucleotides
member
producing
fc
transmitted
regulate
list
presentation
constant
classification
consensus
behavior
heart
transmembrane
great
immediately
thought
migration
restricted
aldrich
implemented
pi
muscle
hev
jev
run
possibly
camels
imaging
regional
tagged
saline
electron
european
normalized
lysates
usage
hospitalized
protect
released
epidemiology
lethal
discussed
kb
datasets
fetal
promising
unclear
women
space
1c
treatments
microarray
cattle
egfp
extracts
subtypes
activate
clearance
involving
monitored
suitable
distributed
fit
vlps
recommended
ev
rhinovirus
endemic
instance
gag
cdc
microglia
month
recovered
sepsis
flag
programs
ros
serve
hadv
repeated
map
synthetic
ebv
mentioned
physical
school
coated
segments
modifications
proteases
naive
alveolar
white
frequent
oxygen
veterinary
lineage
summary
characterization
describe
issues
supporting
reactivity
typical
washing
altered
error
researchers
modification
avoid
1β
interesting
5b
working
array
apoptotic
segment
materials
allowing
text
chosen
city
assigned
encephalitis
household
bd
counts
cpv
pair
inducing
lacking
inhibiting
organisms
driven
hong
substitution
reached
uptake
memory
older
start
uninfected
exhibit
relationships
identifying
articles
capture
mode
organs
assumed
january
cytometry
sex
suspected
protocols
occurrence
complement
person
europe
concern
mapping
h3n2
documented
cut
extended
adjusted
integrated
province
yeast
diagnosed
differentially
problems
quantification
trend
attachment
korea
examination
kong
utr
enveloped
feature
depletion
effector
rat
229e
question
analyze
definition
input
respect
beta
resource
communication
native
tag
heat
respective
partially
randomly
ion
ab
experience
parallel
power
false
glucose
antimicrobial
multiplex
viability
applications
irf3
trypsin
accurate
motifs
hour
dynamic
wells
covs
pkr
details
microscope
hospitalization
movement
facilities
reflect
framework
upregulated
benefit
forming
utilized
consent
exact
polyclonal
aim
ifns
nacl
candidates
enriched
costs
subtype
beads
tm
organ
adapted
conclusions
perform
attention
trees
listed
defense
centrifuged
gc
canine
sampled
starting
comparisons
vesicles
department
turn
count
clade
node
exist
farm
glycoproteins
reservoir
tuberculosis
lysis
allergic
sign
comprehensive
replicates
validation
replicate
pathogenicity
improvement
ev71
composed
discovered
differ
pathology
preventing
homologous
intermediate
occurring
293t
routine
simulation
availability
metabolism
catalytic
challenged
admitted
remove
technique
clinically
immunofluorescence
ncbi
share
involvement
reasons
variability
overlapping
examples
contribution
gp120
practices
intervals
virulent
clustering
locations
bone
periods
persistent
replaced
contributed
vp1
easily
informed
renal
achieve
aspects
conformation
substitutions
tail
crystal
e2
validated
advantage
6a
csf
science
glycosylation
decision
education
hr
injected
dilutions
enrichment
ards
pol
reading
abundant
representing
threat
rich
adverse
establish
categories
begin
copy
reason
adjuvant
overexpression
fractions
hydrophobic
symptom
explore
indirect
liquid
iga
biology
temporal
macrophage
project
apparent
mammals
nl63
explained
homology
m1
investigations
measurements
upstream
subset
dr
qrt
taiwan
referred
shift
transcript
filter
maturation
pdcov
accordance
impaired
ic
image
frameshifting
subject
variations
barrier
constructs
preparedness
ice
layer
codons
epithelium
chains
distributions
oxidative
view
frequencies
kinetics
channel
serotypes
cc
helix
ko
lowest
minor
mix
package
seeded
mva
varied
failed
metabolic
allele
borne
north
characteristic
demographic
knockdown
ligands
modeling
systematic
largest
libraries
zika
equivalent
mosquito
coupled
dendritic
removal
screened
simultaneously
risks
article
feed
depends
niv
nanoparticles
aligned
humoral
bsa
di
living
interacts
died
swab
cardiac
cholesterol
livestock
roche
2d
blotting
issue
sizes
conformational
ratios
fast
independently
questionnaire
situation
stat1
infiltration
objective
protected
implicated
scenario
fresh
respondents
contigs
golgi
cytotoxicity
aids
s4
secreted
passage
orfs
beneficial
presenting
snps
gold
resuspended
fatal
associations
uv
immunogenicity
variance
neutrophil
unlike
ge
complications
balb
attributed
home
communities
explored
maintain
toxicity
electrophoresis
simulations
measurement
pooled
mature
geographic
th1
rrna
syncytial
cp
1h
assembled
circulation
consists
institutional
purpose
neurons
isg15
necrosis
exon
wildlife
parasite
physiological
databases
stay
ribosomal
covid
define
diagnostics
ns3
dual
positively
aimed
ari
ethics
untreated
maintenance
substrates
treat
affecting
4c
journal
raw
concept
oc43
growing
gut
reproductive
safe
agarose
created
regulating
delay
ongoing
throughput
aptamers
heterogeneity
emerged
online
invasion
coefficient
facility
translational
suppression
contamination
feline
gradient
